Make Your Voice Heard on MS Treatment

The Institute for Clinical and Economic Review (ICER) is currently conducting a review of disease-modifying therapies for relapsing-remitting and primary-progressive forms of multiple sclerosis. Insurers may use ICER recommendations to […]

Read News Article